Leopold Sellner
Leopold Sellner
University Hospital Heidelberg
Bestätigte E-Mail-Adresse bei med.uni-heidelberg.de
Zitiert von
Zitiert von
p53-dependent non-coding RNA networks in chronic lymphocytic leukemia
CJ Blume, A Hotz-Wagenblatt, J Hüllein, L Sellner, A Jethwa, T Stolz, ...
Leukemia 29 (10), 2015
Drug-perturbation-based stratification of blood cancer
S Dietrich, M Oleś, J Lu, L Sellner, S Anders, B Velten, B Wu, J Hüllein, ...
The Journal of clinical investigation 128 (1), 427-445, 2018
Lysosome‐targeting amplifiers of reactive oxygen species as anticancer prodrugs
S Daum, MSV Reshetnikov, M Sisa, T Dumych, MD Lootsik, R Bilyy, E Bila, ...
Angewandte Chemie International Edition 56 (49), 15545-15549, 2017
Aminoferrocene-based prodrugs and their effects on human normal and cancer cells as well as bacterial cells
P Marzenell, H Hagen, L Sellner, T Zenz, R Grinyte, V Pavlov, S Daum, ...
Journal of medicinal chemistry 56 (17), 6935-6944, 2013
Discovery of novel drug sensitivities in T-PLL by high-throughput ex vivo drug testing and mutation profiling
EI Andersson, S Pützer, B Yadav, O Dufva, S Khan, L He, L Sellner, ...
Leukemia 32 (3), 774-787, 2018
Autologous retransplantation for patients with recurrent multiple myeloma: a single‐center experience with 200 patients
L Sellner, C Heiss, A Benner, MS Raab, J Hillengass, D Hose, N Lehners, ...
Cancer 119 (13), 2438-2446, 2013
Increased levels of 2-hydroxyglutarate in AML patients with IDH1-R132H and IDH2-R140Q mutations.
L Sellner, D Capper, J Meyer, CD Langhans, CM Hartog, H Pfeifer, ...
European journal of haematology 85 (5), 457-459, 2010
Differences in expansion potential of naive chimeric antigen receptor T cells from healthy donors and untreated chronic lymphocytic leukemia patients
JM Hoffmann, ML Schubert, L Wang, A Hückelhoven, L Sellner, S Stock, ...
Frontiers in immunology 8, 1956, 2018
Improved Synthesis of N-Benzylaminoferrocene-Based Prodrugs and Evaluation of Their Toxicity and Antileukemic Activity
S Daum, VF Chekhun, IN Todor, NY Lukianova, YV Shvets, L Sellner, ...
Journal of medicinal chemistry 58 (4), 2015-2024, 2015
ARResT/Interrogate: an interactive immunoprofiler for IG/TR NGS data
V Bystry, T Reigl, A Krejci, M Demko, B Hanakova, A Grioni, H Knecht, ...
Bioinformatics 33 (3), 435-437, 2017
Chaetoglobosin A preferentially induces apoptosis in chronic lymphocytic leukemia cells by targeting the cytoskeleton
PB Knudsen, B Hanna, S Ohl, L Sellner, T Zenz, H Döhner, ...
Leukemia 28 (6), 1289-1298, 2014
Targeted resequencing for analysis of clonal composition of recurrent gene mutations in chronic lymphocytic leukaemia
A Jethwa, J Hüllein, T Stolz, C Blume, L Sellner, A Jauch, M Sill, AP Kater, ...
British journal of haematology 163 (4), 496-500, 2013
Thiotepa-based high-dose therapy for autologous stem cell transplantation in lymphoma: a retrospective study from the EBMT
L Sellner, A Boumendil, H Finel, S Choquet, G De Rosa, F Falzetti, ...
Bone marrow transplantation 51 (2), 212-218, 2016
Chimeric antigen receptor T cell therapy targeting CD19-positive leukemia and lymphoma in the context of stem cell transplantation
ML Schubert, A Hückelhoven, JM Hoffmann, A Schmitt, P Wuchter, ...
Human gene therapy 27 (10), 758-771, 2016
Neutralization of membrane complement regulators improves complement-dependent effector functions of therapeutic anticancer antibodies targeting leukemic cells
S Mamidi, S Höne, C Teufel, L Sellner, T Zenz, M Kirschfink
Oncoimmunology 4 (3), e979688, 2015
MED12 mutations and NOTCH signalling in chronic lymphocytic leukaemia
B Wu, M Słabicki, L Sellner, S Dietrich, X Liu, A Jethwa, J Hüllein, ...
British journal of haematology 179 (3), 421-429, 2017
Idelalisib for optimized CD19‐specific chimeric antigen receptor T cells in chronic lymphocytic leukemia patients
S Stock, R Übelhart, ML Schubert, F Fan, B He, JM Hoffmann, L Wang, ...
International journal of cancer 145 (5), 1312-1324, 2019
Generation of efficient human blood progenitor–targeted recombinant adeno-associated viral vectors (AAV) by applying an AAV random peptide library on primary human …
L Sellner, M Stiefelhagen, JA Kleinschmidt, S Laufs, F Wenz, S Fruehauf, ...
Experimental hematology 36 (8), 957-964, 2008
Optimizing manufacturing protocols of chimeric antigen receptor T cells for improved anticancer immunotherapy
S Stock, M Schmitt, L Sellner
International journal of molecular sciences 20 (24), 6223, 2019
GvL effects in T-prolymphocytic leukemia: evidence from MRD kinetics and TCR repertoire analyses
L Sellner, M Brüggemann, M Schlitt, H Knecht, D Herrmann, T Reigl, ...
Bone marrow transplantation 52 (4), 544-551, 2017
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20